ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of September 21, 2026, ZTS trades at $72.00 with a market cap of $29.50B and a P/E ratio of 11.82. ZTS moved -1.74% today. Year to date, ZTS is -43.25%; over the trailing twelve months it is -51.46%. Its 52-week range spans $71.00 to $177.40. Analyst consensus is buy with an average price target of $91.25. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ZTS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $72.00 |
| Market Cap | $29.50B |
| P/E Ratio | 11.82 |
| EPS | $6.09 |
| Dividend Yield | 0.53% |
| 52-Week High | $177.40 |
| 52-Week Low | $71.00 |
| Volume | 2.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $9.52B |
| Net Income | $2.62B |
| Gross Margin | 71.53% |
11 analysts cover ZTS: 0 strong buy, 5 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $91.25.